Guggenheim maintained a Buy rating on Merck (NYSE:MRK) shares but reduced the price target to $115 from $122. The adjustment follows a comprehensive review of the pharmaceutical giant's fourth-quarter ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

For the 10th anniversary of America’s Best Large and Midsize Employers, Forbes is recognizing 77 Best Employer ...

As per Intent Market Research, the Cell Analysis Market was valued at USD 19.2 billion in 2023-e and will surpass USD 38.4 billion by 2030; growing at a CAGR of 10.4% during 2024 - 2030.

Australian scientists have found an effective new way to clean up methylmercury, one of the world's most dangerous pollutants ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for scientists. T cells, which are the frontline warriors in the battle against ...

Investing in digital transformation must be part of a broader commitment to security and resilience.Saud bin Sultan Al Qasimi ...

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

The new developers and owners of Russ Research Center aim to recreate success that they have had in redeveloping other commercial centers, including the Piqua Center in Miami County, with the ...

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 33,776.08 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...

Dr. Patrick Heissler, CEO, SCRONA AG, discusses the company’s recently unveiled 128-nozzle electrohydrodynamic (EHD) printhead, which achieves a three-digit nozzle count in digital EHD technology for ...